- The chief executives of the three largest U.S. drug distributors and a drugmaker have been summoned to appear before a federal judge to discuss a proposal to resolve thousands of lawsuits alleging they fueled the U.S. opioid crisis, a person familiar with the matter said on Thursday.
Those companies, along with Johnson & Johnson, have been negotiating a settlement they value at roughly $50 billion that would allow them to resolve 2,600 lawsuits nationally by largely states and localities, people familiar with the matter said. Under the proposal, McKesson, AmerisourceBergen and Cardinal Health would pay $18 billion over 18 years and J&J would pay $4 billion, according to two people familiar with the matter.